Insider screener

Period: 12 months Minimum amount: $1M × Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

7,695 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

7,695 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

7,695 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

7,695 decisions over 12 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
7,695 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
7,695 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

7,695 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
21 Nov 2025
Bought
$22.22M 797,486 at 27.86
5.6%
Largest buy in 3 yrs
21 Nov 2025
Sold at will
$12.94M 21,858 at 592.18
2.6%
Not planned
21 Nov 2025
Foroughi Arash Adam CEO & Chairperson · indirect
Sold at will 36×
$10.26M 20,000 at 513.12
0.7%
Not planned
21 Nov 2025
Ritchie Robert C Chief Executive Officer
Sold at will
$9.03M 475,000 at 19.00
16.2%
Not planned
21 Nov 2025
Cagney Michael Scott Director · indirect
Sold at will 3×
$8.51M 250,000 at 34.06
3.9%
Not planned
21 Nov 2025
Ou June Director
Sold at will 3×
$8.51M 250,000 at 34.06
3.9%
Not planned
21 Nov 2025
Kingsley Lawrence D Director · indirect
Sold at will
$7.15M 300,000 at 23.83
7.1%
Not planned
21 Nov 2025
Karp Alexander C. See Remarks
Sold at will 3×
$7.12M 45,564 at 156.25
0.7%
Not planned
21 Nov 2025
Cohen Stephen Andrew See Remarks
Sold at will 3×
$6.12M 39,136 at 156.25
98.5%
Sold half or more
21 Nov 2025
MURDOCH KEITH RUPERT Chairman Emeritus · indirect
Sold at will
$5.93M 100,000 at 59.26
8.3%
Not planned
21 Nov 2025
Monteleone William President and CEO
Sold at will 2×
$4.28M 99,284 at 43.15
19.0%
Not planned
21 Nov 2025
Herrman Ernie CEO & President
Sold at will
$3.69M 24,363 at 151.31
4.6%
Not planned
21 Nov 2025
Schlitz Lei Zhang VP & Pres, Global Products
Sold at will
$3.63M 32,031 at 113.20
32.4%
Not planned
21 Nov 2025
KIRK RANDAL J Director · indirect
Sold at will
$3.59M 937,308 at 3.83
14.4%
Not planned
21 Nov 2025
Crevoiserat Joanne C. Chief Executive Officer
Sold at will
$3.34M 31,735 at 105.31
4.5%
Not planned
21 Nov 2025
Sold at will
$3.26M 171,800 at 19.00
49.8%
Not planned
21 Nov 2025
Sold at will
$3.16M 29,451 at 107.41
27.0%
Not planned
21 Nov 2025
DOYLE J PATRICK Executive Chairman
Sold at will 3×
$3.04M 43,597 at 69.80
18.4%
Not planned
21 Nov 2025
Bought
$3.00M 2,068,965 at 1.45
18.9%
First buy on file
21 Nov 2025
Sankar Shyam See Remarks
Sold at will 3×
$2.97M 19,004 at 156.25
2.9%
Not planned
21 Nov 2025
Bought
$2.40M 419,477 at 5.73
2.0%
21 Nov 2025
Dimopoulos Christos Executive VP, Global Markets
Sold at will 2×
$2.39M 25,300 at 94.37
19.5%
Not planned
21 Nov 2025
Lampropoulos Fred P. Executive Chairman
Sold at will
$2.18M 25,000 at 87.31
2.4%
Not planned
21 Nov 2025
Stanton Marshall S. SVP, Clinical & MD Affair
Sold at will 4×
$2.13M 47,376 at 45.04
51.4%
Sold half or more
21 Nov 2025
ROBBINS LARRY Director · indirect
Bought
$2.06M 800,000 at 2.58
6.7%
21 Nov 2025
Roe Scott A. CFO and COO
Sold at will
$1.97M 18,794 at 104.85
11.3%
Not planned
21 Nov 2025
Satter Muneer A Director · indirect
Bought
$1.81M 422,613 at 4.28
4.5%
21 Nov 2025
Brady Kevin M. CFO & Treasurer
Sold at will
$1.77M 3,000 at 590.35
33.3%
Not planned
21 Nov 2025
Fraser Jason W. EVP & CFO
Sold at will
$1.73M 9,933 at 174.02
6.9%
Not planned
21 Nov 2025
Sold at will 5×
$1.69M 45,715 at 37.05
88.6%
Sold half or more
21 Nov 2025
STAHLBERG JAN 10% owner · indirect
Bought
$1.55M 208,872 at 7.41
2.5%
21 Nov 2025
Swieringa John PRES, TECH & COO
Sold at will
$1.48M 22,000 at 67.34
7.2%
Not planned
21 Nov 2025
Bought
$1.48M 270,478 at 5.46
0.3%
21 Nov 2025
Rowland David Donnay EVP & Co-Chief Invest. Officer
Sold at will
$1.45M 5,000 at 290.57
22.2%
Not planned
21 Nov 2025
GUSTAVSON JEFF B Vice President
Sold at will
$1.40M 9,325 at 150.27
84.8%
Sold half or more
21 Nov 2025
Madsen Julia Sr. VP and GM, Life Sciences
Sold at will 2×
$1.31M 5,008 at 262.00
31.9%
Not planned
21 Nov 2025
Sahi Levesque Rati Chief Executive Officer
Sold at will 5×
$1.27M 97,036 at 13.06
5.7%
Not planned
21 Nov 2025
Haley Patrick J. EVP, Commercial
Sold at will
$1.19M 28,043 at 42.58
7.0%
Not planned
21 Nov 2025
Husted Amy D. Exec VP General Counsel & Sec
Sold at will
$1.12M 10,413 at 107.42
47.0%
Not planned
21 Nov 2025
Brown Hayden President & CEO
Sold at will
$1.09M 60,000 at 18.20
5.4%
Not planned
21 Nov 2025
Sold at will
$1.09M 20,000 at 54.52
16.9%
Not planned
21 Nov 2025
Bought 2×
$1.01M 70,000 at 14.46
439%
First buy on file
21 Nov 2025
GRASSLE JENELE C Director
Sold at will
$1.01M 2,400 at 420.87
49.0%
Not planned
21 Nov 2025
Mirshekari Ali John Director · indirect
Sold at will
$1.00M 33,933 at 29.53
100%
Sold half or more
20 Nov 2025
MEGACHIPS CORP /FI 10% owner
Sold at will
$102.24M 400,000 at 255.60
10.5%
Not planned
20 Nov 2025
Karp Alexander C. See Remarks
Sold at will 19×
$58.92M 359,325 at 163.99
5.3%
Not planned
20 Nov 2025
Xu Tony CHIEF EXECUTIVE OFFICER
Sold at will 3×
$56.54M 288,410 at 196.04
55.4%
Sold half or more
20 Nov 2025
Cohen Stephen Andrew See Remarks
Sold at will 19×
$50.61M 308,635 at 163.99
99.8%
Sold half or more
20 Nov 2025
Slingsby Brian Taylor Director · indirect
Sold at will
$43.35M 1,000,000 at 43.35
11.2%
Not planned
20 Nov 2025
HESS JOHN B Director · indirect
Sold at will 3×
$41.46M 275,000 at 150.75
19.6%
Not planned
Showing 6,951–7,000 of 7,695. ← Newer Page 140 of 154 Older →